Blog

Blog

By Kevin Hrusovsky, Executive Chairman and CEO, Quanterix

We are privileged to live in a society that values science, technology, engineering and mathematics. Better known as STEM, these programs play a critical role in the advancement of our society, and are shaping the future of medicine and other disciplines. STEM makes it possible for our children to live in a world where diseases can be detected before symptoms are present and developing nations can implement sustainable initiatives to end poverty.

By Kevin Hrusovsky, EXECUTIVE CHAIRMAN AND CEO, QUANTERIX
As a company that believes we have the power to improve player safety, we also know that change cannot happen unless we have unified support from the entire community, including researchers, scientists, doctors, patients, patient advocates, investors, and institutions like the NFL.
By Dr. Mark Roskey and Dr. David Duffy

We were honored to be able to speak about the promise of immuno-oncology (IO) therapeutics at this year’s Molecular Med Tri-Con conference and the 12th Annual Biomarkers Congress. Bringing together thought leaders from around the world, including academics, pharma customers and therapeutic companies, these conferences are critical for the acceleration of precision health for improved treatment methods across a variety of disease-types.

BY KEVIN HRUSOVSKY, CEO AND EXECUTIVE CHAIRMAN, QUANTERIX

2016 has been a banner year for the healthcare and life sciences industries. This year we saw the launch of critical initiatives like the Vice President Biden’s Cancer Moonshot, aimed at improving our ability to prevent cancer and detect it an early stage. As recently as just this month, we saw the passing of the 21st Century Cures Act, an important step forward in transformation of our approach to precision health, in part by providing funding to some of our most promising research initiatives, setting us up to continue to achieve incredible milestones in 2017 and beyond. 

BY KEVIN HRUSOVSKY, CEO AND EXECUTIVE CHAIRMAN, QUANTERIX

Thanks to recent moves by Congress last week, we’re one step closer to transforming the way in which we approach today’s sick care to true, precision healthcare. The 21st Century Cures Act – which includes funding for President Obama’s precision medicine initiative, the cancer “moonshot” effort and Alzheimer’s research – will promote high-risk, high-reward research using special procurement procedures, rather than through conventional grants and contracts, according to The New York Times. It’s a huge moment in history as these important initiatives receive the necessary funding for new research – and one that will bring us closer to preventing devastating diseases.

This website uses cookies. By continuing to use this website you are acknowledging and agree with our cookie policy.

AgreeLearn more